…records over N7bn loss in six months Plans are underway by GlaxoSmithKline (GSK) Nigeria to stop doing business after evaluating the options for moving to a third-party distribution model for its drugs and consumer healthcare goods. In statement on Thursday it said: “For the above reasons, and having, together with GSK UK, evaluated various other options, the Board of GlaxoSmithKline Consumer Nigeria Plc has concluded that there is no alternative but to cease operations.” Shares in GSK Nigeria, in which British drug maker, GSK has a 46.4 per cent stake…
Read MoreGlaxoSmithKline loses N7bn In 6 Months, To Halt Nigerian Operations
